We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (WAS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00774358
First Posted: October 17, 2008
Last Update Posted: August 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Texas Children's Hospital
Information provided by (Responsible Party):
Soma Jyonouchi, Children's Hospital of Philadelphia
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)